Peter Wirth

This is a page dedicated to get more information for investors to evaluate the management style of Peter Wirth who is a Chief Legal Officer of Genzyme Cp.

Here on this page we are inviting all readers to discuss Peter Wirth. You may anonymously post comments with any information that they have about Peter Wirth. You can post comments about their management style or whatever you want to talk about concerning their ability as an executive. Please refrain from personal attacks.

Here is a copy of personal Bio that we found:

Mr. Wirth joined us in January 1996 and has served as Executive Vice President and Chief Legal Officer since September 1996 with responsibility for our corporate development and legal activities. From 2001 through October 2005, Mr. Wirth had responsibility for our drug discovery and development business. In addition, from September 1996 until June 2003, Mr. Wirth was responsible for our Oncology business.